Anders Bendtz Kanstrup

This inventor holds 18 USPTO granted patents, primarily in Heterocyclic Compounds. Top assignees: Novo Nordisk A/s, Karo Bio Ab. Active years: 1994-2007.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anders Bendtz Kanstrup. Retrieved from https://idiyas.com/inventor/anders-bendtz-kanstrup

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18

% Patents Active = 72.2

Average Co-Inventor Count = 3.9

ph-index = 12

Forward Citations = 571(Granted Patents)

Location History:

Virum, DK (1994 - 1998)
Esperg.ae butted.rde, DK (1999)
Esperg.oe butted.rde, DK (2000)
Espergærde, DK (2001)
Espergaerde, DK (2000 - 2007)

Company Filing History:

where one patent can have more than one assignee

Years Active: 1994-2007

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

DPP-IV Inhibitors

Cis-3,4-Chroman Derivatives

Pyrrolo[2,1,5-cd]indolizine

Therapeutically Active Compounds

Indole Compounds

Thieno[2,3-b-Indole Derivatives

Piperidine Compounds

Antagonists

Central Nervous System Diseases

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7235538 - Heterocyclic compounds, which are inhibitors of the enzyme DPP-IV (2007-06-26),

2. 7192952 - Heterocyclic compounds that are inhibitors of the enzyme DPP-IV (2007-03-20),

3. 6869947 - Heterocyclic compounds that are inhibitors of the enzyme DPP-IV (2005-03-22),

4. 6645995 - Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV (2003-11-11),

5. 6380398 - Therapeutically active and selective heterocyclic compounds that are inhibitors of the enzyme DPP-IV (2002-04-30),

6. 6316494 - cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes (2001-11-13),

7. 6080754 - Pyrrolo[2,1,5-cd]indolizine derivatives useful in the prevention or (2000-06-27),

8. 6075036 - Pyrrolo [2,1,5-cd] indolizine derivatives useful in the prevention or (2000-06-13),

9. 6043269 - cis-3,4-chroman derivatives useful in the prevention or treatment of (2000-03-28),

10. 5994390 - Trans-3,4-chroman derivatives useful in the prevention or treatment of (1999-11-30),

11. 5985306 - (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or (1999-11-16),

12. 5958967 - Cis-3,4-chroman derivatives useful in the prevention or treatment of (1999-09-28),

13. 5945417 - Heterocyclic compounds, their preparation and use (1999-08-31),

14. 5919817 - Cis-3, 4-chroman derivatives useful in the prevention or treatment of (1999-07-06),

15. 5783575 - Antagonists, their preparation and use (1998-07-21),

Title: The Innovative Journey of Anders Bendtz Kanstrup

Introduction: Anders Bendtz Kanstrup is a visionary inventor hailing from Espergaerde, Denmark. With a passion for creating groundbreaking solutions, he has made significant contributions to the field of innovation.

Latest Patents: Anders Bendtz Kanstrup holds several patents in various industries, showcasing his versatility and creativity in inventing new technologies to address modern challenges.

Career Highlights: Throughout his career, Anders Bendtz Kanstrup has demonstrated a remarkable ability to transform ideas into tangible inventions. His dedication to pushing the boundaries of innovation has led to the development of cutting-edge products that have made a positive impact on society.

Collaborations: Anders Bendtz Kanstrup has collaborated with leading experts in the field, leveraging their knowledge and expertise to bring his inventions to life. His collaborative spirit has been instrumental in the success of many projects.

Conclusion: Anders Bendtz Kanstrup's innovative spirit and determination have solidified his position as a respected inventor in Espergaerde, Denmark, and beyond. His contributions to the world of innovation continue to inspire others to think outside the box and pursue their creative ideas.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]